Haematologica (Aug 2024)
Comparing the clinical trial efficacy <i>versus</i> real-world effectiveness of treatments for multiple myeloma: a population-based study
- Alissa Visram,
- Kelvin Kar-Wing Chan,
- Hsien Seow,
- Gregory Pond,
- Anastasia Gayowsky,
- Ghulam Rehman Mohyuddin,
- Arleigh McCurdy,
- Irwindeep Sandhu,
- Christopher Venner,
- Guido Lancman,
- Amaris Balitsky,
- Tom Kouroukis,
- Robert Bruins,
- Shaji Kumar,
- Rafael Fonseca,
- Hira Mian
Affiliations
- Alissa Visram
- The Ottawa Hospital Research Institute, Ottawa, Ontario
- Kelvin Kar-Wing Chan
- Department of Medicine, Sunnybrook Health Sciences Center, University of Toronto
- Hsien Seow
- Department of Oncology, McMaster University, Hamilton
- Gregory Pond
- Department of Oncology, McMaster University, Hamilton
- Anastasia Gayowsky
- ICES McMaster, McMaster University, Hamilton, Ontario
- Ghulam Rehman Mohyuddin
- Department of Hematology, Huntsman Cancer Institute, Salt Lake City, Utah
- Arleigh McCurdy
- The Ottawa Hospital Research Institute, Ottawa, Ontario
- Irwindeep Sandhu
- Department of Oncology, University of Edmonton, Edmonton
- Christopher Venner
- Department of Medical Oncology, BC Cancer – Vancouver Centre, University of British Columbia, Vancouver
- Guido Lancman
- Department of Medicine, University of Toronto, Toronto
- Amaris Balitsky
- Department of Oncology, McMaster University, Hamilton
- Tom Kouroukis
- Department of Oncology, McMaster University, Hamilton
- Robert Bruins
- Eli Lilly Canada Inc., Toronto, ON
- Shaji Kumar
- Division of Hematology, Mayo Clinic, Rochester, Minnesota
- Rafael Fonseca
- Division of Hematology/Oncology, Mayo Clinic, Phoenix, Arizona
- Hira Mian
- Department of Oncology, McMaster University, Hamilton
- DOI
- https://doi.org/10.3324/haematol.2024.285768
- Journal volume & issue
-
Vol. 999,
no. 1
Abstract
Not available.
